129 related articles for article (PubMed ID: 9885959)
1. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats.
Jentsch JD; Dazzi L; Chhatwal JP; Verrico CD; Roth RH
Neurosci Lett; 1998 Dec; 258(3):175-8. PubMed ID: 9885959
[TBL] [Abstract][Full Text] [Related]
2. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
Balla A; Sershen H; Serra M; Koneru R; Javitt DC
Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
[TBL] [Abstract][Full Text] [Related]
3. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
4. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.
Yonezawa Y; Kuroki T; Kawahara T; Tashiro N; Uchimura H
Eur J Pharmacol; 1998 Jan; 341(1):45-56. PubMed ID: 9489855
[TBL] [Abstract][Full Text] [Related]
5. Effect of intermittent subchronic MK-801 administration on dopamine synthesis capacity and responsiveness in the prefrontal cortex.
Shibata K; Enomoto K; Tsutsumi T; Muraoka H; Fuwa T; Kawano M; Ishigooka J; Inada K; Nishimura K; Oshibuchi H
Neuropsychopharmacol Rep; 2024 Jun; 44(2):333-341. PubMed ID: 38376999
[TBL] [Abstract][Full Text] [Related]
6. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.
Jentsch JD; Redmond DE; Elsworth JD; Taylor JR; Youngren KD; Roth RH
Science; 1997 Aug; 277(5328):953-5. PubMed ID: 9252326
[TBL] [Abstract][Full Text] [Related]
7. Ceruletide inhibits phencyclidine-induced dopamine and serotonin release in rat prefrontal cortex.
Etou K; Kuroki T; Kawahara T; Yonezawa Y; Tashiro N; Uchimura H
Pharmacol Biochem Behav; 1998 Dec; 61(4):427-34. PubMed ID: 9802838
[TBL] [Abstract][Full Text] [Related]
8. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence.
Jentsch JD; Tran A; Taylor JR; Roth RH
Psychopharmacology (Berl); 1998 Jul; 138(1):89-95. PubMed ID: 9694531
[TBL] [Abstract][Full Text] [Related]
9. Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.
Hondo H; Yonezawa Y; Nakahara T; Nakamura K; Hirano M; Uchimura H; Tashiro N
Brain Res; 1994 Jan; 633(1-2):337-42. PubMed ID: 8137168
[TBL] [Abstract][Full Text] [Related]
10. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat.
Jentsch JD; Tran A; Le D; Youngren KD; Roth RH
Neuropsychopharmacology; 1997 Aug; 17(2):92-9. PubMed ID: 9252984
[TBL] [Abstract][Full Text] [Related]
11. Different roles of group I and group II metabotropic glutamate receptors on phencyclidine-induced dopamine release in the rat prefrontal cortex.
Maeda J; Suhara T; Okauchi T; Semba J
Neurosci Lett; 2003 Jan; 336(3):171-4. PubMed ID: 12505620
[TBL] [Abstract][Full Text] [Related]
12. Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine.
De La Garza R; Jentsch JD; Verrico CD; Roth RH
Brain Res; 2002 Dec; 958(1):20-7. PubMed ID: 12468026
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
14. Prefrontal stimulation of GABAA receptors counteracts the corticolimbic hyperactivity produced by NMDA antagonists in the prefrontal cortex of the rat.
Del Arco A; Ronzoni G; Mora F
Psychopharmacology (Berl); 2011 Mar; 214(2):525-36. PubMed ID: 20981411
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbens.
Del Arco A; Mora F; Mohammed AH; Fuxe K
J Neural Transm (Vienna); 2007 Feb; 114(2):185-93. PubMed ID: 16897609
[TBL] [Abstract][Full Text] [Related]
16. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion.
Jentsch JD; Taylor JR; Roth RH
Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564
[TBL] [Abstract][Full Text] [Related]
17. Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.
Jentsch JD; Elsworth JD; Redmond DE; Roth RH
J Neurosci; 1997 Mar; 17(5):1769-75. PubMed ID: 9030635
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum.
Balla A; Hashim A; Burch S; Javitt DC; Lajtha A; Sershen H
Neurochem Res; 2001 Sep; 26(8-9):1001-6. PubMed ID: 11699927
[TBL] [Abstract][Full Text] [Related]
19. Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats.
Young AM; Stubbendorff C; Valencia M; Gerdjikov TV
Neuroscience; 2015 Feb; 287():157-63. PubMed ID: 25542422
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats.
Kohli S; King MV; Williams S; Edwards A; Ballard TM; Steward LJ; Alberati D; Fone KCF
Neuropsychopharmacology; 2019 Jan; 44(2):295-305. PubMed ID: 30120410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
